4.5 Article

Packaging colour research by tobacco companies: the pack as a product characteristic

Journal

TOBACCO CONTROL
Volume 26, Issue 3, Pages 307-315

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/tobaccocontrol-2015-052656

Keywords

-

Funding

  1. National Cancer Institute from the National Cancer Institute [CA-087472, 1P50CA180890]
  2. Food and Drug Administration Center for Tobacco Products

Ask authors/readers for more resources

Background Tobacco companies use colour on cigarette packaging and labelling to communicate brand imagery, diminish health concerns, and as a replacement for prohibited descriptive words ('light' and 'mild') to make misleading claims about reduced risks. Methods We analysed previously secret tobacco industry documents to identify additional ways in which cigarette companies tested and manipulated pack colours to affect consumers' perceptions of the cigarettes' flavour and strength. Results Cigarette companies' approach to package design is based on 'sensation transference' in which consumers transfer sensations they derive from the packaging to the product itself. Companies manipulate consumers' perceptions of the taste and strength of cigarettes by changing the colour of the packaging. For example, even without changes to the tobacco blends, flavourings or additives, consumers perceive the taste of cigarettes in packages with red and darker colours to be fuller flavoured and stronger, and cigarettes in packs with more white and lighter colours are perceived to taste lighter and be less harmful. Conclusions Companies use pack colours to manipulate consumers' perceptions of the taste, strength and health impacts of the cigarettes inside the packs, thereby altering their characteristics and effectively creating new products. In countries that do not require standardised packaging, regulators should consider colour equivalently to other changes in cigarette characteristics (eg, physical characteristics, ingredients, additives and flavourings) when making determinations about whether or not to permit new products on the market.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Substance Abuse

Tobacco Industry Promotional Strategies Targeting American Indians/Alaska Natives and Exploiting Tribal Sovereignty

Lauren K. Lempert, Stanton A. Glantz

NICOTINE & TOBACCO RESEARCH (2019)

Article Substance Abuse

IQOS labelling will mislead consumers

Karma McKelvey, Lucy Popova, Minji Kim, Lauren Kass Lempert, Benjamin W. Chaffee, Maya Vijayaraghavan, Pamela Ling, Bonnie Halpern-Felsher

TOBACCO CONTROL (2018)

Article Substance Abuse

Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims

Lucy Popova, Lauren Kass Lempert, Stanton A. Glantz

TOBACCO CONTROL (2018)

Article Substance Abuse

Heated tobacco product regulation under US law and the FCTC

Lauren Kass Lempert, Stanton A. Glantz

TOBACCO CONTROL (2018)

Article Substance Abuse

Analysis of FDA's IQOS marketing authorisation and its policy impacts

Lauren Kass Lempert, Stanton Glantz

Summary: After analyzing FDA's review of PMPSA's application, relevant law and guidance on PMTAs, and independent research on IQOS health impacts, it was found that the evidence submitted did not demonstrate long-term disease risk reduction, and that IQOS aerosol emits toxins with carcinogenic and genotoxic potential. Despite recommendations from FDA scientists and independent research showing serious risks associated with IQOS, FDA concluded that it is 'appropriate for the protection of the public health', which may have significant health impacts and undermine public confidence in future PMTA decisions.

TOBACCO CONTROL (2021)

Article Medicine, General & Internal

Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic

Shivani Mathur Gaiha, Lauren Kass Lempert, Bonnie Halpern-Felsher

JAMA NETWORK OPEN (2020)

Article Substance Abuse

FDA's reduced exposure marketing order for IQOS: why it is not a reliable global model

Lauren Kass Lempert, Stella Bialous, Stanton Glantz

Summary: The US FDA authorized Philip Morris Products S.A. to market IQOS in the USA, claiming reduced exposure to harmful substances but prohibiting reduced harm claims. Philip Morris International used this decision to promote IQOS globally and pressure governments to reverse HTP regulations. WHO Framework Convention on Tobacco Control parties should reject unsubstantiated claims of reduced harm associated with HTPs and resist calls to relax regulations based on FDA actions.

TOBACCO CONTROL (2022)

Article Public, Environmental & Occupational Health

Emerging Indoor Air Laws for Onsite Cannabis Consumption Businesses in the US

Thomas L. Rotering, Lauren K. Lempert, Stanton A. Glantz

Summary: As of June 10, 2020, 6 out of 11 states and the District of Columbia allow onsite consumption of cannabis, with at least 56 localities within these states permitting onsite cannabis consumption. Most of these localities do not explicitly ban indoor smoking or vaping, highlighting the need for education of policymakers to enhance their understanding of secondhand smoke mitigation.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2021)

Article Psychology, Clinical

E-cigarette devices, brands, and flavors attract youth: Informing FDA's policies and priorities to close critical gaps

Shivani Mathur Gaiha, Lauren Kass Lempert, Karma McKelvey, Bonnie Halpern-Felsher

Summary: The study found that during the period of flavor restrictions and youth access laws, as well as the COVID-19 pandemic, adolescents and young adults were more likely to use disposable e-cigarettes and those with mint/menthol, fruit, and sweet/dessert/candy flavors. Additionally, some participants also used flavor enhancers.

ADDICTIVE BEHAVIORS (2022)

Article Environmental Sciences

Flavored Tobacco Sales Restrictions Reduce Tobacco Product Availability and Retailer Advertising

Louisa M. Holmes, Lauren Kass Lempert, Pamela M. Ling

Summary: This study found that the implementation of flavored tobacco sales restrictions in Alameda and San Francisco Counties led to a decrease in the availability and advertising of flavored tobacco products. Category 1 cities, which had enacted the policies, showed a significant reduction in availability and advertising compared to Category 2 cities. These findings suggest that comprehensive sales restriction policies can help prevent youth tobacco initiation and exposure.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Medicine, General & Internal

Use Patterns, Flavors, Brands, and Ingredients of Nonnicotine e-Cigarettes Among Adolescents, Young Adults, and Adults in the United States

Shivani Mathur Gaiha, Crystal Lin, Lauren Kass Lempert, Bonnie Halpern-Felsher

Summary: This study examined the usage patterns of nonnicotine e-cigarettes among adolescents, young adults, and adults in the United States, revealing a significant proportion of individuals who reported using nonnicotine e-cigarettes and co-using them with nicotine e-cigarettes. The survey also highlighted common flavors, brands, and ingredients used.

JAMA NETWORK OPEN (2022)

Article Environmental Sciences

Adolescents, Young Adults, and Adults Continue to Use E-Cigarette Devices and Flavors Two Years after FDA Discretionary Enforcement

Devin M. McCauley, Shivani Mathur Gaiha, Lauren Kass Lempert, Bonnie Halpern-Felsher

Summary: This study assessed the use of e-cigarette devices and flavors among adolescents, young adults, and adults, revealing differences in usage patterns and flavor preferences across age groups. Findings suggest that current e-cigarette use among adolescents and young adults may be higher than previously reported.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Substance Abuse

Vuse Solo e-cigarettes do not provide net benefits to public health: a scientific analysis of FDA's marketing authorisation

Stanton Glantz, Lauren Kass Lempert

Summary: The FDA authorized the marketing of RJ Reynolds Vapor Company's Vuse Solo e-cigarette through the PMTA pathway. However, the FDA's scientific justification had deficiencies, including not adequately considering the popularity of Vuse among youth and evidence of its impact on nicotine market expansion and cigarette smoking. Therefore, the FDA should reconsider its marketing order for Vuse and should not use it as a template for other e-cigarette PMTAs.

TOBACCO CONTROL (2023)

Article Social Sciences, Interdisciplinary

Impacts of Tax and Flavor Tobacco Policies on San Francisco Bay Area Tobacco Prices

Vira Pravosud, Louisa M. Holmes, Lauren K. Lempert, Pamela M. Ling

Summary: California Proposition 56 increased tobacco tax, SF enacted local flavored tobacco sales restrictions, and the Cigarette Litter Abatement Fee was increased. This study compares the change in tobacco prices before and after the tax increase and local policies, and found that the price increase was higher in SF than Alameda County. Local flavor policies affected menthol product availability and increased pack prices.

EVALUATION REVIEW (2023)

Editorial Material Substance Abuse

TAAT and the rise of hemp cigarettes

Lauren Kass Lempert

TOBACCO CONTROL (2023)

No Data Available